I.
General Objective
This study aims to present the case of a patient diagnosed with Kawasaki
Disease and highlight the nursing management associated with the medical care
provided to a patient with such a disease.
II.
Specific Objectives
The following serve as a guide the accomplishment of the main objective:
1. Since Kawasaki Disease is a rare yet potentially debilitating disease mostly
seen in children, one of the goals of this study is to expand the knowledge
and appreciation of the disease by presenting its clinical manifestations,
complications, treatment, and prognoses;
2. Kawasaki Disease is a systemic vasculitic disease with possible affectations
of the heart, coronary arteries, skin, and lymph vessels, hence, this study
aims to promote the nursing interventions needed for the symptomatic
treatment of the disease;
3. The incidence and treatment of Kawasaki Disease in the Philippines is not
well documented, therefore, another goal of this study is to potentially serve
as a significant reference for other researchers who wish to expand local
knowledge about the disease.
INTRODUCTION
1
I.
coronary artery aneurysms and stenoses, and coronary thrombosis which may
lead to myocardial infarction, sudden death, or congestive heart failure. About
twenty-five percent (25%) of untreated KD patients develop coronary artery
aneurysms.
KD was first observed and diagnosed in 1961 by Dr. Tomisaku Kawasaki
at the Japan Red Cross Medical Center in Tokyo. Between 1961 to 1967, Dr.
Kawasaki reported fifty (50) infants and young children who presented with
several signs that included prolonged remittent fever, unilateral cervical
lymphadenitis, bilateral conjunctival injection, polymorphous erythematous rash,
erythema and edema of the hands and feet, inflammation of the lips and oral
cavity, and subsequent desquamation of the fingers, toes, and periungual area.
He ruled out other possible diagnoses after negative laboratory results and was
convinced that he was treating a unique clinical syndrome. The first recorded
case that had cardiac involvement was in 1968, when Kawasaki and a colleague
reported a client manifesting with tachycardia, abnormal heart rhythm, and
cardiomegaly. Several years after, Kawasaki presented post-mortem evidence of
a number of patients diagnosed with KD who died due to coronary artery
complications.
KD is known to cause outbreaks in Japan, where the incidence of the
disease is about 150 to 175 cases per 100,000 children or more than 10,000 new
cases per year. In the United States, the incidence is about 15 per 100,000
children or less than 4,000 new cases per year.
2
II.
However,
possible risk factors and causes have been researched and studied to identify
the cause of the disease
1. Age
More than 90% of KD cases occur in children less than ten years of age.
Eighty-five percent (85%) of cases were diagnosed in patients less than five
years old and 50% in children younger than two years of age.
2. Gender
The ratio of male to female patients with KD is 1.5:1 internationally. It is
evidently more common in males than in females.
3. Race
Worldwide, Japan has the highest rate of incidence with approximately
10,000 new cases yearly. KD has been known to cause outbreaks in Japan
usually during the winter and spring seasons.
incidence is roughly 4,000 new cases yearly with rates intermediate among
African-Americans and those with Asian and South Pacific ancestry other
than Japan. In the Philippines, concrete data about the annual rate of KD is
not present.
The cause of KD is idiopathic although some studies suggest it to be
infectious. The bases for this assumption are the outbreaks reported in Japan
and the United States during the winter and spring seasons where the incidence
of KD doubles compared to the summer and fall seasons. Another reason for
this assumption is the fact that the acute stage of KD is self-limiting even without
IVIG medication.
The following possible pathologic agents have been suggested:
1. Parvovirus and Rotavirus infection
2. HIV
3
3. Rubella
4. Meningococcal septicemia
5. Klebsiella pneumoniae bacteremia
6. Coxiella burnettie
7. Human lymphotropic virus infection
III.
Clinical Manifestations
Kawasaki Disease has diagnostic criteria to distinguish it from other
diseases with similar clinical manifestations.
1. Fever for at least 5 days with at least four (4) of the following features:
2. Bilateral conjuctival injection
3. Polymorphous exanthema or rashes
4. Changes in the lips and oral cavity (i.e. erythema, cracked lips, strawberry
tongue)
5. Changes in the peripheral extremities (i.e. edema in the hands and feet,
desquamation of fingers, toes, and periungual area)
6. Unilateral cervical lymphodenopathy (palpable; at least 1.5cm in diameter)
7. Exclusion of other diseases with similar presentations
The following signs and symptoms are present in the disease during its
stages:
Acute Stage (Days 1 to 11)
High fever
Irritability
Bilateral conjunctivitis
Rashes
Unilateral lymphadenitis
Thrombocytosis
Decreased temperature
Arthritis or arthralgia
IV.
Sterile pyuria
5
medical
treatment
for
Kawasaki
Disease
is
intravenous
DOSAGE
2g/kg infusion over 10 to 12
FREQUENCY
Single dose
hours OR;
400mg/kg/day
For 4 days
In 4 divided
doses until
14h day of
illness and
patient is
afebrile for at
least 3-4 days
3-5mg/kg/day
PATIENT PROFILE
I.
Demographic Data
Name: Patient CDC
Age: 1.5 years old
7
II.
Age: 33 y/o
Age: 38y/o
Temperature 39.5C
Cardiac Rate 120 bpm
Respiration Rate 30 cpm
Blood Pressure 90/60 mmHg
He was later
V.
Nutritional History
Patient CDC was breastfed for the first 2 weeks after birth. A milk formula
was given from 2 weeks after birth to present. Ratio of formula is 1:1 milk to
water given 6 ounces every 2 hours.
Patient started eating cereals, meat, fruits, fish, and vegetables on the
sixth (6th) month. Twenty-four (24) hours prior to confinement, patient ate bread
and milk for breakfast, and rice and soup for lunch and dinner.
Patient is given Celine for vitamins.
Patient has no known food allergies.
VI.
VII.
10
PHYSICAL ASSESSMENT
Name: Patient CDC
Age: 1 years old
Sex: Female
Department: Ward 1-C
Diagnosis: Kawasaki Disease.
Date and Time of Assessment: January 29, 2010 4:00 PM
I.
General Survey
Received patient lying on bed, awake and responsive, not in any respiratory distress. With IVF of
0.9% NaCl 1000cc at right arm KVO. The patient measures 81cm in height and weighs 11.5kg. Patient appears to
be restless and irritable as evidenced by increased movement and uncontrollable crying. Patient does not appear
to be in respiratory distress.
II.
Vital Signs
Techniques: Inspection, Palpation, Auscultation
Patient has temperature of 38.4C, axillary with cardiac rate of 121 beats per minute, regular respiratory rate
of 32 breaths per minute, and blood pressure of 90/60 mmHg.
11
PART
Skin
Head
TECHNIQUE
Inspection
and
Palpation
Inspection
and
Palpation
NORMAL FINDINGS
Color varies from light to
deep brown
No edema
Skin temperature is
uniform within normal
range
Skin temperature is
uniformly warm due to
elevated body
temperature
Configuration is
normocephalic
No lesions or tenderness
12
ACTUAL FINDINGS
Erythematous and
maculopapular rashes
are present on the back,
abdomen, chest, and
extremities
Head is normocephalic in
shape
Absence of lesions and no
signs of tenderness
INTERPRETATION
Presence of
erythematous and
maculopapular rashes
is one criteria in
diagnosis of Kawasaki
Disease
Changes in the
peripheral extremities
such as edema and
desquamation are
criteria for diagnosing
Kawasaki Disease
Changes in the
peripheral extremities
such as edema and
desquamation are
criteria for diagnosing
Kawasaki Disease
Temperature of 38.4C
upon assessment;
persistent fever for at
least 5 days is the
earliest sign of
Kawasaki Disease
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Normal
Normal
Normal
Normal
Hair
Inspection
Eyes:
Sclera
Inspection
Appears white
Bilateral non-purulent
conjunctival injection
is one of the signs of
Kawasaki Disease
Cornea
Inspection
Transparent, shiny,
smooth with corneal
details visible
Transparent, shiny,
smooth; details apparent
Normal
Pupils
Inspection
Black/brown in color;
constricts when
illuminated and when
looking at near objects;
dilates when looking at far
objects
Symmetrically aligned
Normal
Aligned
Normal
Eye Balls
Inspection
13
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Palpebral
and Bulbar
Conjuctiva
Ears
Inspection
Inspecton
and
Palpation
Nose
Mouth
Inspection
and
Palpation
Inspection
and
Palpation
Neck
Inspection
and
Neck is symmetrical
Thyroid glands are not
14
Bilateral conjunctival
injection is one of the
criteria in diagnosing
Kawasaki Disease
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Normal
Normal
Normal
Normal
Normal
Changes in the mouth
and oral mucosa are
some of the signs of
Kawasaki Disease
Neck is symmetrical
Presence of a swollen
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Normal
Unilateral cervical
Palpation
Chest
Heart
Inspection,
Palpation,
Auscultation
Auscultation
Inspection
lymphodenopathy
appears in 50% to 75%
of patients with
Kawasaki Disease
Normal
Normal
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Normal
Breathing is abdominal
and posterior mobility and
posture of thorax is
symmetrical upon
respiration
Abdominal breathing is
present (pediatric) with
thoracic movement
symmetrical
Normal
Normal
No presence of harsh
breath sounds; patient was
crying and irritable during
assessment
S1 and S2 are heard
audibly on apical and base
areas of the heart
No murmur or gallops (S3
and S4)
Normal
Normal
Breast
15
Smooth texture
Intact epidermis
Capillary refill in 3-5
seconds
Finger and
Toe Nails
Abdomen
Inspection
and
Palpation
Inspection,
Auscultation,
Palpation
Normal
Normal
Smooth texture
Intact epidermis
Capillary refill of 3 seconds
Changes in
extremities such as
edema, desquamation,
and redness are signs
of Kawasaki Disease
Normal
Normal
Normal
Unblemished skin,
uniform in color
Presence of
erythematous and
polymorphous rashes on
the trunk
no evidence of liver
enlargement
Audible bowel sounds
no evidence of liver
enlargement
Audible bowel sounds at
12 per minute; abdomen
produces a growling sound
16
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Cherry, James D.
Presence of
polymorphous
exanthema or rashes
is one sign of
Kawasaki Disease
Normal
Normal
Source: Textbook of
Pediatric Infectious
Diseases, Fifth Edition by
Feigin, Ralph D. and
Muscles
Cherry, James D.
Normal
Inspection,
Palpation
17
ANATOMY
Kawasaki Disease, otherwise known as Mucocutaneous Lymph Node Syndrome,
is an acute, self-limiting, and febrile systemic vasculitis that may cause cardiac
complications. The most common sequel of KD is coronary thrombosis (stagnant blood
clot) that possibly leads to the development of a coronary aneurysm. Having these
definitions and descriptions of the disease in mind, the following body systems and
structures will be discussed briefly to illustrate the physiological effects of KD.
I.
Heart
The heart functions as the primary organ for blood circulation in the
human body.
venous system to the lungs and oxygenated blood from the lungs to the arterial
circulation.
(arterial) circulation to bring nutrients, vital enzymes, hormones, and drugs to the
tissues and organs of the body. The image of the heart, its parts and functions,
are illustrated in Figure 1 and Table 1 respectively.
FIGURE 1: THE HEART AND ITS STRUCTURES
18
FUNCTION
One of the two main veins that drains unoxygenated blood to the right atrium
Aorta
Pulmonary Artery
circulation
The only artery in the body that carries
deoxygenated blood
Pulmonary Vein
Right Atrium
Right Ventricle
pulmonary artery
Receives oxygenated blood from the
pulmonary vein
Left Ventricle
Atrioventricular Valves
circulation
The tricuspid and mitral valves ensure
one-way blood flow within the chambers
of the heart
Semilunar Valves
20
II.
Coronary Arteries
The coronary arteries constitute the coronary circulation that supplies
oxygenated blood to the heart itself. These arteries receive their blood supply
from openings in the aorta called the coronary ostia.
A major complication of Kawasaki Disease is the development of coronary
aneurysms and coronary thrombosis, thus making the discussion of the coronary
arteries relevant. Ruptured coronary aneurysms lead to massive bleeding and
ischemia, eventually resulting to myocardial infarction.
The main branches of the coronary arteries and the areas of the heart
they supply are detailed below (Figure 2 and Table 2).
Figure 2: The Coronary Circulation
21
PARTS SUPPLIED
Circumflex Artery
Right Coronary Artery
interventricular septum
Supplies blood to left atrium and the lateral
22
III.
Vascular System
The vascular system is made up of the arteries and veins of the body.
Arteries branch into smaller arterioles, which branch further into capillaries.
Capillaries serve as the site where nutrient exchange between the blood and
tissues occur. Blood from the capillaries then enter venules that eventually join
together to form larger veins. The arteries serve as the channels for oxygenated
blood (systemic circulation) and the veins serve as the channels for
deoxygenated blood.
As a systemic vasculitic disease, Kawasaki Disease causes inflammation
of the blood vessels resulting to edema, increased permeability of the vessels,
and coronary aneurysms (weakening of the blood vessel walls). Figure 3 and
Table 3 briefly discuss the structure and functions of the vascular components.
Figure 3: The Vascular System
23
PARTS
Tunica Adventitia (outer
media
Thicker than the tunica
layer)
Tunica Media (middle
adventitia allowing
VEINS
Thickest layer
Thinner in veins
layer)
vasoconstriction and
vasodilation
Same
Narrower
Absent
valves
Present; to ensure the oneway flow of blood back to
Blood Flow
the heart
Slow in the venules, but
increases speed as it
(valve-related)
Superior and inferior vena
subclavian artery,
brachiocephalic, abdominal
24
IV.
Lymph Nodes
The lymph nodes are some of the major structures of the lymphatic
system, which works closely with the circulatory system to bring interstitial fluid
back into the blood circulation. Functionally, however, lymph nodes are part of
the hematologic and immune systems because large numbers of lymphocytes,
monocytes, and macrophages reside in these nodes. These cells are mobilized
and join the circulating blood during infection or inflammation.
In Kawasaki Disease, there is unilateral lymphodenopathy, meaning that
the lymph nodes enlarge due to inflammation. What causes this inflammation is
still unknown, but since unilateral lymphodenopathy is one criterion in diagnosing
KD, it is worth to include it in the anatomy section of this study.
Figure 6: Parts of a Lymph Node
26
27
PATHOPHYSIOLOGY
Signs and symptoms in
patient
Diagnosis of Kawasaki
Disease based on
diagnostic criteria of
disease;
Age is the only probable
predisposing factor in
patient
Complications if untreated
without IVIG 10 days after onset
of fever
Diagnostic indicators
(+) fever
(+) maculopapular
erythematous rashes on
hands, feet, trunk, and
abdomen;
(+) edema of hands and
feet;
(+) desquamation of
fingers, toes, and
periungual area
Coronary aneurysm;
Coronary thrombosis;
Coronary stenosis;
Coronary arteritis
Myocardial infarction;
Congestive heart
failure;
Death
Sources:
1. Textbook of Pediatric Infectious Diseases Fifth Edition by Feigin, Ralph D. and
Cherry, James D.
2. Kawasaki Disease by Scheinfeld, Noah S. and Jones, Elena L.
http://emedicine.medscape.com/article/965367-overview
28
Discussion:
The etiology of Kawasaki Disease is still unknown. Studies have failed to identify
a pathologic agent that causes the disease. Most clinicians believe the disease has an
infectious nature due to the presence of seasonal outbreaks in Japan. The only nonmodifiable risk factors with considerable theoretical basis are age and race. Most cases
involve children below 10 years of age and Japanese children appear to be at a higher
risk of acquiring the disease. However, the incidence of KD in Asians and other Pacific
Islanders is higher compared to Westerners of Caucasian or African descent.
The patient manifested 5 out of the 6 signs in the criteria for diagnosing
Kawasaki Disease. The patient had remittent fever for 6 days, had rashes that started
in the arms and spread to the trunk, oral cavity changes manifested by cracked lips,
strawberry tongue, and reddened oral mucosa, bilateral conjunctivitis, and a palpable
lymph node on the lefts side of the neck. These clinical manifestations were supported
by the hematological test and vital signs of the patient: a temperature of 39.5C,
elevated platelet (thrombocytosis) and ESR (inflammatory response) levels, and a left
shift (increased production of mature leukocytes) in the patients WBC differential
results. The hematological results further provide evidence of the multi-system
affectations of the disease indicating signs of inflammation (vasculitis in KD), formation
of blood clots, and abnormal increase in WBCs (manifested in lymphadenopathy.
Twenty-five percent (25%) of cases result to coronary artery complications
without IVIG therapy and 3% of cases lead to the same complications even with IVIG
therapy. The coronary artery complications include formation of blood clots, arterial
stenosis, arteritis, and aneurysms. If these complications are not detected, the worstcase prognoses are myocardial infarction, congestive heart failure, and death. KD has a
0.1 to 2% mortality rate globally.
29
DIAGNOSTIC EXAMINATIONS
Hematology Section - PCMC
Name: Patient CDC
Date received: January 26, 2010 - 9:34 pm
Date released: January 26, 2010 - 10:34 pm
PARAMETERS
RESULTS
NORMAL
VALUES
Hemoglobin
(HGB)
107.6
116-140g/L
Hematocrit
(HCT)
0.34
0.35-0.41g/L
RBC
4.36
3.6-50g/L
WBC
19.7
5-10g/L
Differential Count
30
FINDINGS
ANALYSIS
Below normal
Indicative of
anemia, which
is a diagnostic
predictor of
Kawasaki
Disease
Slightly below
normal
Lysis of RBC
is possibly
due to
vasculitic
affects of
disease
Normal
There is no
abnormal
finding
Remarkably
above normal
Indicative of
leukocytosis
secondary to
infection or
inflammation
PARAMETERS
RESULTS
NORMAL
VALUES
FINDINGS
ANALYSIS
Eosinophils
0.01
0.02-0.07hpf
Slightly below
normal
Possibly due to
allergic
reactions
Segmenter
0.85
0.55-0.65 hpf
Remarkably
above normal
Overproduction
of mature
leukocytes
indicative of
increased
autoimmune
response
Lymphocytes
0.14
0.25-0.35 hpf
Remarkably
below normal
Indicative of
immunosuppression
Platelet Count
411
150-350 x
103 /L hpf
Remarkably
above normal
Indicative of
thrombocytosis,
which appears
on the 2nd week
of Kawasaki
Disease
ESR
112
0 -20 mm/hr
Remarkably
above normal
Indicative of
inflammatory
response
RESULTS
NORMAL
VALUES
Hemoglobin
(HGB)
106
Hematocrit
(HCT)
0.32
0.35-0.41g/L
Erythrocyte
Count
3.7
Leukocyte
Count
Platelet Count
116-140g/L
FINDINGS
ANALYSIS
Below normal
Indicative of
anemia
Slightly below
normal
Indicative of
low RBC
count due to
hematologic
factors
3.6-50g/L
Normal
Within normal
range
5.75
5-10g/L
Normal
Within normal
range
98,000
150,000
300,000
Below normal
Indicative of
thrombocytopenia
Differential Count
PARAMETERS
RESULTS
NORMAL
VALUES
Eosinophils
0.03
0.02-0.07hpf
Normal
Within normal
range
Segmenter
0.55
0.55-0.65 hpf
Normal
Within normal
range
Lymphocytes
0.40
0.25-0.35 hpf
Slightly above
normal
Indicative of
autoimmune
response
Monocytes
0.02
0.02-0.05
Normal
Within normal
32
FINDINGS
ANALYSIS
range
33
DRUG STUDY
DRUG
DOSAGE
MECHANISM OF
ACTION
Drug Name:
2.5g/50ml 10 vials:
IMMUNOGLOBULIN IV
Test Dose I:
0.01x11.5kgx60
= 7cc for 30mins
Improves immunity
by binding to and
neutralizing
pathogens, thereby
increasing
antibodies against
bacterial, viral,
parasitic, and
mycoplasmic
antigens. Acts
through
antimicrobial and
antitoxin
neutralization.
Drug Class:
Passive immuneglobulin
INDICATION
Kawasaki
Syndrome
Prophylaxis after
exposure to
Hepatitis A
B-cell chronic
lymphocytic
leukemia
CONTRAINDICATION
Patients with
anaphylactic reaction to
IGIV
ADVERSE
EFFECT
Tenderness,
muscle stiffness at
injection site,
nausea, vomiting,
chills, fever,
headache.
NURSING
RESPONSIBILITIES
- Do not administer to
patients with history of
allergy to gammaglobulin
- Instruct patient to report
symptoms occurring
during or after therapy.
- Use with caution in
pregnant womenPregnancy C; safety not
established
Pediatric HIV
infection
Translate
remaining 390cc to
24cc/hr for 16hrs
34
DRUG
Drug Name:
ASPIRIN
Classification:
Antipyretic,
analgesic, NSAID
DOSAGE
300mg/tab; 1 tab
q6 PO
MECHANISM OF
ACTION
It acts in the
thermoregulatory
center of the
hypothalamus to
block effects of
pyrogen
Also has antiinflammatory, antiplatelet, and
analgesic
properties
INDICATION
CONTRAINDICATION
Mild to moderate
pain
Allergy to NSAID or
salicylates
Fever
Hemophilia;
hemorrhagic states;
impaired renal function;
chickenpox; pregnancy
Inflammatory
conditionsrheumatic fever,
rheumatoid
arthritis,
osteoarthritis
35
ADVERSE
EFFECT
Acute aspirin
toxicity: tachypnea,
hemorrhage,
excitement,
confusion
GI: nausea,
dyspepsia,
heartburn,
epigastric
discomfort,
anorexia
NURSING
RESPONSIBILITIES
- Give drug with food or
after meals if GI upset
occurs.
- Use the drug only as
suggested; avoid
overdose.
II.
36
DIAGNOSIS
Elevated body
temperature
related to
systemic
inflammation
of blood
vessels
secondary to
present
disease
INFERENCE
Present
disease
Systemic
inflammation
of blood
vessels
PLANNING
Short-term:
INTERVENTION
Independent:
After 2 hours
of nursing
intervention,
the patients
temperature
will normalize
at 37.5C.
Check
temperature and
other vital signs
prior to
interventions;
Assessment
of all vital
signs is
integral to
planning and
intervention;
Administer tepid
sponge bath to
lower
temperature;
TSB is an
independent
nursing
function that
lowers core
temperature;
Provide a change
of clothes and
sheets to promote
increased
comfort;
Increasing
patient
comfort can
ease irritability
and
restlessness
associated
with fever;
Regularly check
diapers if soiled;
Soiled diapers
cause
additional
discomfort;
Release of
pyrogens
Elevated body
temperature
37
RATIONALE
EVALUATION
After 2 hours of
nursing
intervention, the
patients body
temperature
was lowered to
37.8C; to
continue
interventions
until body
temperature
normalizes
Follow feeding
schedule to
provide nutritional
support;
Infants require
sufficient
nutrition
especially
during times
of illness and
immunosuppression;
Dehydration is
common in
infants with
persistent
fever
Dependent:
Administer aspirin
as ordered;
Aspirin serves
as an
antipyretic,
antiinflammatory
and antiplatelet drug
in Kawasaki
Disease
Check the flow
Proper
rate of IVIG and
regulation of
watch out for
IVIG infusion
signs of adverse
is important to
effects
prevent side
effects
2. Impaired skin integrity related to accumulation of fluid in the interstitial spaces of hands and feet secondary to
present disease
38
ASSESSMENT
Subjective:
NONE
Objective:
+ 1 edema of
hands and feet;
Skin appears dry
and shiny;
With erythema of
hands and feet;
desquamation of
fingers and toes
DIAGNOSIS
Impaired skin
integrity
related to
accumulation
of fluids in
interstitial
spaces of
hands and
feet
secondary to
present
disease
INFERENCE
Present
disease
Systemic
inflammation
of blood
vessels
Increase in
histamine
release
Greater
permeability
of blood
vessels
Vascular fluid
moving to
interstitial
spaces of
hands and
feet
PLANNING
Short-term:
After 6 hours
of nursing
intervention,
skin integrity
improved as
evidenced by
controlled
dryness of the
skin
Long-term:
After 3 to 4
days of
nursing
intervention,
skin integrity
problems
related to
edema will
resolve as
evidenced by
edema score
of 0 from +1
Impaired skin
39
INTERVENTION
Independent:
RATIONALE
Assessment
of sites of
edema will
dictate
provision
interventions;
Assess mobility of
fingers, toes,
hands, feet,
wrists, and
ankles;
Mobility is a
sign of
sufficient
blood flow to
sites;
Apply RICE
technique in
management of
edema;
R- rest;
I ice to
decrease
inflammation;
C
compression
to promote
venous return
and lymphatic
drainage of
fluid;
E elevate
above the
heart for
venous return;
Lotion can
EVALUATION
After 6 hours of
nursing
intervention,
skin integrity
improved with
controlled
dryness of the
skin ; skin is
more moist on
sites of edema
integrity
hasten further
drying of the
skin due to
edema;
Desquamated
skin will peel
off naturally;
you can cut
loose skin at
the ends;
Edema and
dryness make
skin
susceptible to
wounds
Dependent:
Administer aspirin
as prescribed;
Check flow of
IVIG as
prescribed
Aspirin has
antiinflammatory
properties;
IVIG therapy
aids in abating
inflammation,
thus reducing
edema
3. Impaired oral mucous membrane related to inflamed oral mucosa secondary to present disease
ASSESSMENT
Subjective:
DIAGNOSIS
Impaired oral
INFERENCE
Present
PLANNING
Short-term:
40
INTERVENTION
Independent:
RATIONALE
EVALUATION
After 3 hours of
NONE
Objective:
With fissured,
cracked lips;
With
erythematous
lips;
mucous
membrane
related to
inflamed oral
mucosa
secondary to
present
disease
disease
Inflamed oral
mucosa
Poor blood
perfusion to
oral mucous
membrane
Impaired oral
mucous
membrane
(evidenced by
cracked lips)
After 3 hours
of nursing
intervention,
fissures and
cracks in the
lips will be
controlled and
lessened
Long-term:
After 3 to 4
days of
nursing
intervention,
fissures and
cracks will
resolve as
evidenced by
moist lips with
the absence
of cracks and
fissures
41
Assessment
of the fissures
and cracks on
the lips will
affect
interventions
to be given;
Assess if there is
difficulty in
swallowing or
alterations in
feeding;
Fissured and
cracked lips
can cause
difficulty in
feeding,
especially in
infants;
Provide oral
rinses using tap
water or saline
drops to moisten
mucosa;
Moistening
dried mucosa
will prevent
worsening of
cracks and
prevent new
ones from
developing
Provide regular
oral care hygiene
by giving oral
rinses;
Encourage
sufficient fluid
Non-alcoholic
rinses will
prevent
infection
Dehydration
can contribute
nursing
interventions,
fissured and
cracked lips
were managed
as evidenced by
controlled
dryness of the
lips
intake as
prescribed and
tolerated;
to mucosal
dryness and
worsen
cracked lips;
Instruct mother to
avoid giving acidic
fluids;
Juices and
other acidic
beverages
cause pain in
open oral
mucosa;
Instruct mother to
continue feeding
practices as
prescribed by
physician
Feeding
practices
should be
encouraged in
spite of
condition
Further drying
of mucosa can
lead to ulcers
and result to
infection
Independent:
Administer aspirin
as prescribed
42
Aspirin has
analgesic and
antiinflammatory
properties
DIAGNOSIS
Risk for
decreased
cardiac output
related to
INFERENCE
Present
disease
PLANNING
Short-term:
INTERVENTION
Independent:
After 2 hours
of nursing
Assess the
patients cardiac
43
RATIONALE
It is important
to retrieve
EVALUATION
After 2 hours of
nursing
intervention, the
parents were
None
possible
coronary
artery
complications
secondary to
present
disease
Increased
platelet
production
intervention,
the parents
will be able to
verbalize
understanding
Formation of of the cardiac
blood clots in complications
blood vessels, of present
particularly
disease
the coronary
arteries
Blood clots
can cause
blockage,
aneurysms,
and stenosis
of coronary
arteries
All these
complications
can cause
decreased
cardiac output
baseline VS
prior to
discharge for
reference;
Discuss with
parents the nature
of Kawasaki
Disease and the
possible
complications
even with IVIG
therapy;
Client
education is
important in
comprehension of illness
Provide parents
with an
information sheet
regarding postdrug therapy care
for patients with
Kawasaki
Disease;
A quick
reference
guide can
increase
understanding of
disease;
Gradual
reintroduction
able to
understand the
risk for cardiac
complications
as evidenced by
verbalization of
their
comprehension
of health
teachings
45
reintroduce
patient to
activities;
to activities
will help
patient adapt
efficiently after
illness;
Educate patients
on signs of
cardiac problems;
Signs of
cardiac
complications
involve
shortness of
breath, activity
intolerance,
difficulty in
breathing,
dizziness,
lethargy, and
chest pain;
Promote a
balanced diet with
low sodium
content;
Proper
nutrition will
ensure growth
and
development;
Advise parents
regarding follow
up check-up and
diagnostic
procedures
Follow up
check-ups will
help
determine
development
of any cardiac
abnormalities
or coronary
artery
affectations
46
DISCHARGE PLANNING
Medication
Aspirin: advise parents to give drug after meals to prevent gastric irritation
Aspirin: advise parents regarding side effects of drug such as nausea, vomiting,
abdominal pain, and headache
IVIG: educate parents regarding side effects of drug such as chills, fever, and
headache
Advise parents to report any changes in the patient related to drugs being taken
Exercise
Advise parents of adequate rest and sleep for up to 2 to 3 days after discharge to
promote recovery
Advise parents to gradually increase activities; start with light activities until
tolerated before engaging in more strenuous activities
Encourage parents to have patient engage in normal activities of daily living such
as self-feeding, dressing, and walking
Constantly monitor activity and exercise pattern to detect any abnormalities such
as cardiac affectations/sequelae of Kawasaki Disease
Treatment
Health Teachings
Advise mother to complete all immunizations and booster shots for patient once
cleared by physician
Out Patient
Diet
Encourage to have the three basic food groups in the diet while controlling salt
intake
Encourage to prepare foods that are rich in vitamins and minerals to improve
immune system
Continue milk feeding and solid food combination and introduce new viands to
improve appetite and expand food variety
Spiritual
Guided by the family, help the patient to establish deep personal relationship with
God in everyday of her waking moment
With guidance from parents and family, help the patient find happiness in her
present situation
48
REFERENCES
Books
Feigin, Ralph D. et al., Textbook of Pediatric Infectious Diseases Volume 1. Fifth
Edition. Elsevier Inc., Philadelphia, USA: 2004.
Huether, Sue E. and McCance, Kathryn L.,Understanding Pathophysiology 3rd Edition.
Mosby Inc., Singapore: 2004.
Kozier, Barbara et al., Fundamentals of Nursing: Concepts, Process, and Practice
Seventh Edition. Prentice Hall, New Jersey, USA: 2004.
Pillitteri, Adele, Maternal & Child Health Nursing: Care of the Childbrearing &
Childrearing Family Volume 2 Fifth Edition. Lippincott Williams & Wilkins, USA:
2007.
Internet
Gordon, John B. et al. When Children with Kawasaki Disease Grow Up: Myocardial and
Vascular Complications in Adulthood., Journal of the American College of Cardiology
as seen on http://www.medscape.com/viewarticle/712188
Moran, Adrian M. et al. Abnormal Myocardial Mechanics in Kawasaki Disease: Rapid
Response to Gamma-Globulin., American Heart Journal 02/01/2000 as seen on
http://www.medscape.com/viewarticle/409087
Scheinfeld, Noah S. and Jones, Elena L. Kawasaki Disease., 10/20/2009 as seen on
http://emedicine.medscape.com/article/965367-overview
https://www.homeworkping.com/
50